Monitoring Plan

A number of site-specific factors must first be evaluated. Including (1) the chemical characteristics and amount of hazardous waste, (2) the potential for release to the environment, (3) the sensitivity of the particular environment to the hazardous waste, (4) the proximity of the hazardous waste to humans, and (5) Its potential effect on human health. Then the environmental engineer must decide If a field Investigation of the site Is necessary, whether a feasibility study for remedial action Is required, what remedial action Is required to mitigate. If not eliminate, the contamination, and finally, what monitoring plan will enable the efficacy of the remedial action to be evaluated. 

A single monitoring well can be designed to accommodate all of these uses and wells are usually designed to collect only those data required by the groundwater monitoring plan. 

Unconsolidated or weakly consolidated sediments sometimes collapse around the well screen before the filter pack can be installed. This phenomenon is called formation collapse . Formation collapse can occur as a result of the inherently unstable nature of certain sediments or the disruptive nature of the drilling process. Formation collapse is most common below the water table. Although steps can be taken to minimize the amount of collapse, it may not be entirely preventable. The groundwater monitoring plan may need to accept natural formation material as the filter pack for some or all of the screen section. Well development activities (see Section 2.1.6) can be designed to maximize the effectiveness of the formation collapse materials as a filter pack. 

The goal of a groundwater monitoring plan for pesticides is to produce water samples that are representative of the aquifer under study at the time of sample collection. Materials and methods must be established prior to implementing a monitoring program... 

Construct an appropriate monitoring plan to assess hypertension treatment. 

Formulate a monitoring plan for the nonpharmacologic and pharmacologic treatment of a patient with heart failure. 

Identify a monitoring plan to assess for efficacy and toxicity of the recommended drug therapy. 

Formulate a monitoring plan to assess effectiveness and adverse effects of an ischemic heart disease drug regimen. 

Formulate a monitoring plan for a patient with ST-segment elevation acute coronary syndrome receiving fibrinolytics, aspirin, unfractionated heparin, intravenous nitroglycerin, intravenous (3-blockers followed by oral P-blockers, an angiotensin-converting enzyme inhibitor, and a statin. 

Devise a pharmacotherapy treatment and monitoring plan for a patient with non-ST-segment elevation acute coronary syndrome given patient-specific data. 

Develop specific drug therapy monitoring plans for the treatment plan implemented. Monitoring includes assessment of symptoms, ECG, adverse effects of drugs, and potential drug interactions. 

Should BA be given vitamin K If yes, discuss the dose, route of administration, and an appropriate patient monitoring plan. 

The development of CHD is a lifelong process. Except in rare cases of severely elevated serum cholesterol levels, years of poor dietary habits, sedentary lifestyle, and life-habit risk factors (e.g., smoking and obesity) contribute to the development of atherosclerosis.3 Unfortunately, many individuals at risk for CHD do not receive lipid-lowering therapy or are not optimally treated. This chapter will help identify individuals at risk, assess treatment goals based on the level of CHD risk, and implement optimal treatment strategies and monitoring plans. 

Employ an individualized patient monitoring plan in an effort to minimize side effects and maintain treatment adherence and lipid goals. 

Outline a treatment plan for this patient that includes nonpharmacologic therapy, pharmacologic therapy, and a monitoring plan. Justify your therapeutic selections. 

Prepare a patient-specific self-monitoring plan and review it with the patient. Educate the patient on the signs and symptoms of asthma deterioration and when and how to take rescue actions. 

Formulate monitoring plans for acute and chronic CF pharmacologic therapies. 

Develop a monitoring plan to assess antibiotic response. 

Perform pharmacokinetic adjustments as necessary. Recommend a monitoring plan for the antibiotic course. Are any other laboratory tests necessary Are signs of toxicity present ... 

Outline a monitoring plan to evaluate the treatment outcomes for nausea and vomiting. 

Recommend an appropriate monitoring plan to assess the effectiveness of pharmacotherapy for CKD and specific consequences. 

Develop a monitoring plan for a patient placed on specific medications. 

Recommend an appropriate choice of analgesic, dose, and monitoring plan for a patient based on type and severity of pain and other patient-specific parameters. 

---